A detailed history of Graypoint LLC transactions in Novartis Ag stock. As of the latest transaction made, Graypoint LLC holds 3,741 shares of NVS stock, worth $367,927. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,741
Previous 3,759 0.48%
Holding current value
$367,927
Previous $400,000 7.5%
% of portfolio
0.03%
Previous 0.03%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$106.13 - $120.89 $1,910 - $2,176
-18 Reduced 0.48%
3,741 $430,000
Q2 2024

Jul 31, 2024

SELL
$92.57 - $107.37 $176,716 - $204,969
-1,909 Reduced 33.68%
3,759 $400,000
Q1 2024

May 02, 2024

SELL
$95.27 - $108.47 $3,906 - $4,447
-41 Reduced 0.72%
5,668 $548,000
Q4 2023

Jan 29, 2024

SELL
$92.27 - $101.54 $121,611 - $133,829
-1,318 Reduced 18.76%
5,709 $576,000
Q3 2023

Oct 26, 2023

SELL
$94.73 - $105.13 $24,156 - $26,808
-255 Reduced 3.5%
7,027 $715,000
Q2 2023

Jul 21, 2023

SELL
$92.52 - $104.91 $55,974 - $63,470
-605 Reduced 7.67%
7,282 $734,000
Q1 2023

May 02, 2023

SELL
$80.03 - $92.81 $127,967 - $148,403
-1,599 Reduced 16.86%
7,887 $725,000
Q4 2022

Jan 31, 2023

SELL
$75.55 - $92.52 $8,763 - $10,732
-116 Reduced 1.21%
9,486 $860,000
Q3 2022

Oct 31, 2022

BUY
$74.61 - $87.26 $2,089 - $2,443
28 Added 0.29%
9,602 $730,000
Q2 2022

Aug 01, 2022

SELL
$80.52 - $93.75 $10,628 - $12,375
-132 Reduced 1.36%
9,574 $809,000
Q1 2022

Apr 19, 2022

SELL
$80.11 - $90.62 $3,604 - $4,077
-45 Reduced 0.46%
9,706 $852,000
Q4 2021

Jan 31, 2022

SELL
$79.7 - $88.13 $29,409 - $32,519
-369 Reduced 3.65%
9,751 $853,000
Q3 2021

Nov 09, 2021

BUY
$81.78 - $95.14 $16,110 - $18,742
197 Added 1.99%
10,120 $828,000
Q2 2021

Aug 04, 2021

SELL
$85.24 - $94.15 $52,593 - $58,090
-617 Reduced 5.85%
9,923 $905,000
Q1 2021

May 07, 2021

SELL
$83.5 - $98.47 $86,172 - $101,621
-1,032 Reduced 8.92%
10,540 $901,000
Q4 2020

Feb 05, 2021

SELL
$78.07 - $94.43 $164,415 - $198,869
-2,106 Reduced 15.4%
11,572 $1.09 Million
Q3 2020

Nov 02, 2020

SELL
$82.14 - $91.0 $185,882 - $205,933
-2,263 Reduced 14.2%
13,678 $1.19 Million
Q2 2020

Jul 30, 2020

BUY
$80.93 - $91.1 $88,699 - $99,845
1,096 Added 7.38%
15,941 $1.39 Million
Q1 2020

Apr 30, 2020

BUY
$70.67 - $99.01 $1.05 Million - $1.47 Million
14,845 New
14,845 $1.22 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Graypoint LLC Portfolio

Follow Graypoint LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graypoint LLC, based on Form 13F filings with the SEC.

News

Stay updated on Graypoint LLC with notifications on news.